The present application relates to novel substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines, to a method for producing same, to the use thereof either alone or in combinations for treating and/or preventing diseases, and to the use thereof for producing medicinal drugs for the treatment and/or prevention of diseases. The compounds act as stimulators of the soluble guanylate cyclases and are particularly suitable for treating and/or preventing cardiovascular diseases.